Get all your news in one place.
100's of premium titles.
One app.
Start reading
Reuters
Reuters
Business

UK to trial use of COVID-19 survivors' blood plasma for treatment

The United Kingdom is preparing to collect the blood from COVID-19 survivors to investigate if convalescent plasma transfusions could improve an infected patient's speed of recovery and chances of survival.

"NHS Blood and Transplant is preparing to collect COVID-19 convalescent plasma from people who have recovered from this illness," a spokeswoman said. "We envisage that this will be initially used in trials as a possible treatment for COVID-19."

"If fully approved, the trials will investigate whether convalescent plasma transfusions could improve a COVID-19 patient’s speed of recovery and chances of survival," the blood service said.

"We are working closely with the government and all relevant bodies to move through the approvals process as quickly as possible."

People who have recovered from COVID-19 can register with the NHS if they are interested in donating plasma but they should not just turn up at blood donation centres.

(Reporting by Guy Faulconbridge; Editing by Alistair Smout and Michael Holden)

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.